📖
CDK4/6 Inhibitors in the Treatment of Advanced ER/PR-Positive, HER2-Negative Breast Cancer: An Updated Single-Center Analysis of Real-World Data.
Rambow AC, Schröder TJ, Wagenpfeil G, Jansen P, Le HD, Rogmans C, Tribian N, Maass N, van Mackelenbergh M

CDK4/6 Inhibitors in the Treatment of Advanced ER/PR-Positive, HER2-Negative Breast Cancer: An Updated Single-Center Analysis of Real-World Data.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Breast Care (Basel).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title CDK4/6 Inhibitors in the Treatment of Advanced ER/PR-Positive, HER2-Negative Breast Cancer: An Updated Single-Center Analysis of Real-World Data.
Author / Organization Rambow AC, Schröder TJ, Wagenpfeil G, Jansen P, Le HD, Rogmans C, Tribian N, Maass N, van Mackelenbergh M
Subject & Discipline Breast Care (Basel)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-50496
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »